Zurzuvae

(Zuranolone)

Zurzuvae

Drug updated on 1/16/2024

Dosage FormCapsule (oral; 20 mg, 25 mg, and 30 mg)
Drug ClassNeuroactive steroid gamma-aminobutyric acid A receptor positive modulators
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of postpartum depression in adults.

Product Monograph / Prescribing Information

Document TitleYearSource
Zurzuvae (zuranolone) Prescribing Information. 2023Sage Therapeutics, Inc., Cambridge, MA

Systematic Reviews / Meta-Analyses